Article
RNA nanotherapeutics for hepatocellular carcinoma treatment
2 Dec 2024
Abstract excerpt
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, particularly due to the limited effectiveness of current therapeutic options for advanced-stage disease. The efficacy of traditional treatments is often compromised by the intricate liver microenvironment and the inherent heterogeneity. RNA-based therapeutics offer a promising alternative, utilizing the innovative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
